Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Peripheral blood monocyte count reflecting tumor-infiltrating macrophages is a predictive factor of adverse pathology in radical prostatectomy specimens.
Hayashi T, Fujita K, Nojima S, Hayashi Y, Nakano K, Ishizuya Y, Wang C, Yamamoto Y, Kinouchi T, Matsuzaki K, Kawamura N, Jingushi K, Kawashima A, Nagahara A, Ujike T, Uemura M, Imamura R, Morii E, Nonomura N. Hayashi T, et al. Among authors: ishizuya y. Prostate. 2017 Oct;77(14):1383-1388. doi: 10.1002/pros.23398. Epub 2017 Aug 28. Prostate. 2017. PMID: 28845570
The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancer.
Ishizuya Y, Uemura M, Narumi R, Tomiyama E, Koh Y, Matsushita M, Nakano K, Hayashi Y, Wang C, Kato T, Hatano K, Kawashima A, Ujike T, Fujita K, Imamura R, Adachi J, Tomonaga T, Nonomura N. Ishizuya Y, et al. Biochem Biophys Res Commun. 2020 Mar 12;523(3):588-594. doi: 10.1016/j.bbrc.2019.12.084. Epub 2020 Jan 12. Biochem Biophys Res Commun. 2020. PMID: 31941606 Free article.
MicroRNA-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma.
Wang C, Uemura M, Tomiyama E, Matsushita M, Koh Y, Nakano K, Hayashi Y, Ishizuya Y, Jingushi K, Kato T, Hatano K, Kawashima A, Ujike T, Nagahara A, Fujita K, Imamura R, Tsujikawa K, Nonomura N. Wang C, et al. Among authors: ishizuya y. Cancer Sci. 2020 Apr;111(4):1146-1155. doi: 10.1111/cas.14325. Epub 2020 Feb 19. Cancer Sci. 2020. PMID: 31975504 Free PMC article.
Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer.
Hayashi Y, Fujita K, Matsuzaki K, Eich ML, Tomiyama E, Matsushita M, Koh Y, Nakano K, Wang C, Ishizuya Y, Kato T, Hatano K, Kawashima A, Ujike T, Uemura M, Imamura R, Netto GJ, Nonomura N. Hayashi Y, et al. Among authors: ishizuya y. Front Oncol. 2020 May 19;10:755. doi: 10.3389/fonc.2020.00755. eCollection 2020. Front Oncol. 2020. PMID: 32509577 Free PMC article.
TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer.
Hayashi Y, Fujita K, Nojima S, Tomiyama E, Matsushita M, Koh Y, Nakano K, Wang C, Ishizuya Y, Kato T, Hatano K, Kawashima A, Ujike T, Uemura M, Imamura R, Morii E, Nonomura N. Hayashi Y, et al. Among authors: ishizuya y. Mol Oncol. 2020 Oct;14(10):2375-2383. doi: 10.1002/1878-0261.12746. Epub 2020 Jun 27. Mol Oncol. 2020. PMID: 32533903 Free PMC article.
A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell Carcinoma.
Kato T, Tomiyama E, Koh Y, Matsushita M, Hayashi Y, Nakano K, Ishizuya YU, Wang C, Hatano K, Kawashima A, Ujike T, Kawasaki K, Morii E, Gotoh K, Eguchi H, Kiyotani K, Fujita K, Nonomura N, Uemura M. Kato T, et al. Among authors: ishizuya yu. Anticancer Res. 2020 Sep;40(9):4875-4883. doi: 10.21873/anticanres.14490. Anticancer Res. 2020. PMID: 32878775
49 results